6th Ace Drug Discovery Summit 

18th – 19th Feb 2026

About Us

The 6th Ace Drug Discovery Summit in London, UK, serves as a premier platform bringing together global leaders in pharmaceutical science, biotechnology, and AI. Our mission is to drive innovation and collaboration in drug discovery by showcasing cutting-edge research, transformative technologies, and real-world applications. This summit bridges the gap between academia, industry, and clinical practice, covering themes such as AI-driven drug design, in vitro model evolution, translational research, and next-generation therapeutics. With a curated agenda featuring expert presentations, dynamic panel discussions, and strategic business meetings, we aim to accelerate the development of safe, effective, and personalized treatments. From antibody design using synthetic biology to structure-based drug development and breakthroughs in cell and gene therapy, we spotlight the latest trends and challenges shaping the future of drug website discovery. Join us as we advance scientific excellence and build a community committed to transforming global healthcare.

Why Attend

Attendees
0 +
Speakers
0 +
Companies
0 +
Networking Hours
0 +

Solutions at ADDS

The 6th Ace Drug Discovery Summit, London 2026, is a premier gathering of global experts, researchers, and innovators focused on the latest advancements in drug discovery and development.  common and

🔷Antibody Engineering
🔷Biochemistry
🔷Bio-informatics
🔷ADMUPI (Toxicology)
🔷Biomarker Validation
🔷Combinatorial Chemistry
🔷Covering Biological studies
🔷Data Management Technology 

🔷Digital Imaging Technology
🔷Discovery Outsourcing Services
🔷DNA & RNA Analysis
🔷DNA Sequencing Services
🔷 Drug Discovery Technology Platforms
🔷Gene Expression Profiling Solutions
🔷Preclinical
🔷Principal Scientists
🔷Protein identification Services

🔷Research & Development
🔷Transgenesis Services
🔷Genomics
🔷High Throughput Screening
🔷Lead Optimatisation and Profiling, HTS
🔷 Licensing
🔷lmaging/biomarker
🔷Imaging Tools

Who Will Attend

The 6th Ace Drug Discovery Summit, London 2026, is a premier gathering of global experts, researchers, and innovators focused on the latest advancements in drug discovery and development.  common and

🔷CEO
🔷CSO
🔷Director Discovery Alliances
🔷Director of Discovery Strategy Portfolio
🔷Director of Screening & Compound Profiling

🔷Executive Director Chemistry
🔷Head of DMPK
🔷Head of Drug Design
🔷Head of Molecular Toxicology

🔷VP Target Discovery & Assessment
🔷Head of R&D Licensing
🔷Head Pharmacology & Toxicology
🔷Principal Scientist
🔷Senior Director Discovery Research

Thought Leaders

Norman Miller

Co-Founder And CSO
| Kutanios Ltd

 

Asif Ahmed 

Founder And CEO |
MIRZYME THERAPEUTICS LIMITED

John Maher

CSO |
Leucid Bio

Jamie Cartland

Client Partner | Causaly

Mark Eccleston

CEO | ValiRx

Mikko Turunen

Founder, CSO |
RNatives Inc.

Sanjib Bhakta

Professor of Molecular Microbiology And Biochemistry |
UCL And Birkbeck, University of London

Gergely Toth

CEO & CSO |
Cantabio Pharmaceuticals

Kraiem Merabet Manel

CDO | SKYMAB BIOTHERAPEUTICS

Adele Rowley

Chief Scientific Officer | Mironid

Patrizia Anna d’Alessio

CEO |
 AISA Therapeutics

Maria Carmen Visus Miguel

Senior Director R&D Operations | AOP HEALTH

Philip M Arlen

CEO | Precision Biologics

Shayoni Dutta

Data Science Manager | GSK

Kayleigh Thirlwell

Senior Director | Resolution Therapeutics

Alan PALMER

CEO | Elixa Mediscience

Monica Reis

Group Leader | Resolution Therapeutics

Nahuel Villegas

CSO | Vivan Therapeutics

Duygu Dikicioglu

Associate Professor in Digital Bioprocess Engineering | University of College London

Juan Carlos Mobarec

Head Computational Structural Biology | Astrazeneca

Sara Hegy

Founder Coach and Scientist | GenX Leadership Academy

Stephen Harrison

Founder | Chiton Biosciences

Kathryn Armour

Principal Scientist | LifeArc

SONIA MACIA ESCALANTE

Chief Medical Officer | OneChain Immunotherapeutics

John Spencer

Professor/Director of MedChem, SDDC | Sussex Drug Discovery Centre

Darcie Mulhearn

Target Discovery Team Leader | PhoreMost

Vasiliki E Kalodimou

Director Flow Cytometry-Research and Regenerative Medicine | EUC Frankfurt Branch

Morten Grunnet

Vice President, Head of Neuroscience | Lundbeck

Alejandra Tomas

Professor of Cell Biology |
Imperial College London

Jonathan Mason

Senior Research Advisor, Computational Chemistry |
Centessa Pharmaceuticals

Our Sponsors

10x_GENOMICS_LOGO

Attendee Breakdown

Attendee Demographics

2026 Conference Themes

18 February

Oncolytic Peptides – Turning Cold Tumors Hot
Silico Structure-Based ADMET Prediction in Drug Discovery
AI-driven Drug Design, Screening and Optimization
 Strategies for Predictability Neuroscience Diseases
Bioinformatics and Drug Discovery
The Evolution of in vitro models
Artifical Superintelligent Systems

19 February

Revolutionizing Drug Discovery
NKG2D CAR-T based Immunotherapy of Solid Tumors
Deep Learning for Drug Discovery
Target Discovery and Validation for Emerging Therapeutic
Artificial Intelligence in Drug Discovery and Development
Translational Research in Drug Discovery and Development
Structure-Based Drug Design for Targeting RNA

Our Partners

Media Partners

Venue - The Insurance Hall London, UK

The Insurance Hall London has been the home of the UK Insurance sector for over 80 years. It is a prestigious and impressive event venue steeped in history, heritage and architectural significance, a hidden gem in one of City of London’s most decorated and prestigious buildings.

A Grade II listed building formally opened by His Majesty King George V in 1934, The Insurance Hall offers exceptional and flexible event spaces for conferences, receptions, AGMs, business breakfasts, meetings, lunches and dinners for up to 300 delegates.

Join industry leaders at the 6 th Ace Drug Discovery Summit London 2026.